Ticker Details
Soleno Therapeutics, Inc. Common Stock Soleno Therapeutics Inc is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases.
IPO Date:	November 10, 2014
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$2.72B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.48 | 3.60%
Avg Daily Range (30 D):	$1.01 | 2.82%
Avg Daily Range (90 D):	$1.11 | 2.67%

Institutional Daily Volume
Avg Daily Volume:	.68M
Avg Daily Volume (30 D):	4.52M
Avg Daily Volume (90 D):	2.36M

Trade Size
Avg Trade Size (Sh.):	129
Avg Trade Size (Sh.) (30 D):	138
Avg Trade Size (Sh.) (90 D):	96

Institutional Trades
Total Institutional Trades:	2,876
Avg Institutional Trade:	$2.95M
Avg Institutional Trade (30 D):	$3.58M
Avg Institutional Trade (90 D):	$3.34M
Avg Institutional Trade Volume:	.06M
Avg Institutional Trades (Per Day):	4

Market Closing Trades
Avg Closing Trade:	$5.85M
Avg Closing Trade (30 D):	$8.65M
Avg Closing Trade (90 D):	$7.88M
Avg Closing Volume:	109.39K

News

Apr 10, 2026 @ 12:58 AM ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Super... Source: Rosen Law Firm

Apr 9, 2026 @ 10:36 PM ROSEN, A LEADING LAW FIRM, Encourages Eos Energy E... Source: Rosen Law Firm

Apr 9, 2026 @ 10:35 PM ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encoura... Source: Rosen Law Firm

Apr 8, 2026 @ 9:45 PM INVESTOR ALERT: Soleno Therapeutics Inc. (SLNO) In... Source: Robbins Geller Rudman & Dowd Llp

Apr 8, 2026 @ 1:44 AM Gemini Space Station, Inc. Notice of May 18, 2026 ... Source: Kahn Swick & Foti, Llc

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$.4	$.85	$.4
Diluted EPS	$.39	$.84	$.39
Revenue	$190.41M	$91.73M	$190.41M
Gross Profit	$187.71M	$90.87M	$187.71M
Net Income / Loss	$20.89M	$43.36M	$20.89M
Operating Income / Loss	$9.41M	$39.58M	$9.41M
Cost of Revenue	$2.7M	$.86M	$2.7M
Net Cash Flow	$-17.82M	$-176.56M	$-17.82M
PE Ratio	134.95

Splits
Aug 26, 2022	1:15
Oct 06, 2017	1:5